These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 21457401)

  • 1. Current and emerging antiglycaemic pharmacological therapies: the renal perspective.
    Sharif A
    Nephrology (Carlton); 2011 Jul; 16(5):468-75. PubMed ID: 21457401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early clinical assessment of glucose metabolism in renal allograft recipients: diagnosis and prediction of post-transplant diabetes mellitus (PTDM).
    Kuypers DR; Claes K; Bammens B; Evenepoel P; Vanrenterghem Y
    Nephrol Dial Transplant; 2008 Jun; 23(6):2033-42. PubMed ID: 18174264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidiabetic therapy in post kidney transplantation diabetes mellitus.
    Werzowa J; Säemann M; Haidinger M; Krebs M; Hecking M
    Transplant Rev (Orlando); 2015 Jul; 29(3):145-53. PubMed ID: 25641399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosiglitazone is a safe and effective treatment option of new-onset diabetes mellitus after renal transplantation.
    Pietruck F; Kribben A; Van TN; Patschan D; Herget-Rosenthal S; Janssen O; Mann K; Philipp T; Witzke O
    Transpl Int; 2005 Apr; 18(4):483-6. PubMed ID: 15773972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post transplantation diabetes mellitus in kidney allograft recipients: current concepts.
    Nwankwo EA; Bakari AA; Ene AC
    Saudi J Kidney Dis Transpl; 2008 Nov; 19(6):904-10. PubMed ID: 18974574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward improved glycemic control in diabetes. What's on the horizon?
    Gray H; O'Rahilly S
    Arch Intern Med; 1995 Jun; 155(11):1137-42. PubMed ID: 7763119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immediate in-patient management of hyperglycaemia--confusion rather than consensus?
    Penfold S; Gouni R; Hamilton P; Richardson T; Kerr D
    QJM; 2008 Feb; 101(2):87-90. PubMed ID: 18180257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Insulin requirement in patients with type 1 diabetes with reduced renal function: human insulin versus analogue insulin].
    Hasslacher C; Vogt C; Raupp D; Dreyhaupt J
    Dtsch Med Wochenschr; 2007 Nov; 132(47):2500-4. PubMed ID: 18027324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incretin-based therapy in chronic kidney disease.
    Pinelli NR; Moore CL; Tomasello S
    Adv Chronic Kidney Dis; 2010 Sep; 17(5):439-49. PubMed ID: 20727514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Practical management of oral antidiabetics in patients with renal disease].
    Alcazar R; Gonzalez Albarran O; Honorato J; Robles NR; Acha J; de Alvaro F; Fernandez Gallego V; Gomez Garcia P; Lopez de la Torre M; Martinez Castelao A; Romero R
    Nefrologia; 2006; 26(5):538-58. PubMed ID: 17117897
    [No Abstract]   [Full Text] [Related]  

  • 11. The renal effects of blood glucose-lowering plant-derived extracts in diabetes mellitus--an overview.
    Mapanga RF; Musabayane CT
    Ren Fail; 2010 Jan; 32(1):132-8. PubMed ID: 20113279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of new-onset diabetes mellitus after transplantation.
    Reynolds LR; Tannock LR
    Postgrad Med; 2008 Jul; 120(2):60-6. PubMed ID: 18654070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the current therapeutic armamentarium in diabetes enough to control the epidemic and its consequences? What are the current shortcomings?
    Giugliano D; Standl E; Vilsbøll T; Betteridge J; Bonadonna R; Campbell IW; Schernthaner GH; Staels B; Trichopoulou A; Farinaro E
    Acta Diabetol; 2009 Sep; 46(3):173-81. PubMed ID: 19543848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin site wound in a renal allograft recipient.
    Gupta A; Lal C; Dogra PM; Mahajan S; Agarwal SK
    Saudi J Kidney Dis Transpl; 2011 Jan; 22(1):134-5. PubMed ID: 21196630
    [No Abstract]   [Full Text] [Related]  

  • 16. Glipizide treatment of post-transplant diabetes does not interfere with cyclosporine pharmacokinetics in renal allograft recipients.
    Sagedal S; Asberg A; Hartmann A; Bergan S; Berg KJ
    Clin Transplant; 1998 Dec; 12(6):553-6. PubMed ID: 9850449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A polymorphism in the zinc transporter gene SLC30A8 confers resistance against posttransplantation diabetes mellitus in renal allograft recipients.
    Kang ES; Kim MS; Kim YS; Kim CH; Han SJ; Chun SW; Hur KY; Nam CM; Ahn CW; Cha BS; Kim SI; Lee HC
    Diabetes; 2008 Apr; 57(4):1043-7. PubMed ID: 18162509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of diabetes in patients with chronic kidney disease.
    Ahmed Z; Simon B; Choudhury D
    Postgrad Med; 2009 May; 121(3):52-60. PubMed ID: 19491540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin therapy in renal disease.
    Iglesias P; Díez JJ
    Diabetes Obes Metab; 2008 Sep; 10(10):811-23. PubMed ID: 18248491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trials for treatment of NODAT: time to collaborate.
    Sharif A; de Vries AP; Porrini E; Hecking M; Saemann M;
    Transplantation; 2012 Aug; 94(4):e23-4; author reply e24-5. PubMed ID: 22914113
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.